Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Aclarion Adds Institute of Neuro Innovation to Support Nociscan Growth and Real-World Evidence Generation
-
Aclarion Technology Demonstrates Potential Beyond Surgical Planning in New Immune Biomarker Study
-
Aclarion Comments on Echo Lake Capital’s Letter and Unsolicited Proposal
-
10X Health announces the launch of two new supplements designed to support daily movement and blood flow circulation
-
Covering five recent reports, the review examines how advances in biotechnology are supporting protein production, therapeutic innovation and life sciences
-
Aclarion Announces Inducement Grant to New Commercial Director, Western U.S.
-
Aclarion Delivers Strong Q1 2026 Results with 196% Annual Scan Volume Growth Reflecting Accelerating Clinical Adoption
-
Buntanetap improved cognition in pTau217-positive early AD patientsThe drug reduced neurotoxic proteins as well as biomarkers of neuroinflammation and neurodegenerationBuntanetap was safe and...
-
Aclarion Appoints Daniel Keefe as Commercial Director, Western U.S., to Drive Continued Adoption of Nociscan
-
Aclarion Announces $2.5 Million Stock Repurchase Plan